Skip to main content
    C

    Certara Inc (CERT)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $11.39
    -0.18 (-1.56%)

    Market Cap: $1.76B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Certara Inc (CERT) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Certara (CERT) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Certara reported EPS of $0.06, above the $0.05 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    40%(10/25)
    Avg Surprise
    +4.36%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.10
    Range$0.09 - $0.13
    15 analysts
    Revenue Consensus
    $96.90M
    Range$87.77M - $105.63M
    14 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.09
    Range$0.08 - $0.10
    8 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.11-12.3%
    60d ago$0.11-12.3%
    30d ago$0.10-11.2%
    7d ago$0.10-9.4%
    Current$0.09
    Revenue Consensus
    $96.70M
    Range$91.50M - $101.30M
    7 analysts

    Next Report

    CERT has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 100.0% above the $0.05 reported for the quarter ended Dec 31, 2025.

    CERT Earnings Call

    The latest CERT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 25 quarters below that had an estimate, CERT beat 10, missed 11 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $94.90M, up 4.4% from $90.89M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.06$0.05N/A+20.00%Beat-57.1%110 up, 7 downNov 5, 2026$94.90M
    Jun 30, 2026$0.05$0.06N/A-16.67%Miss-28.6%91 up, 0 downAug 4, 2026$93.27M
    Mar 31, 2026$0.09$0.11$0.09 - $0.12-18.18%Miss-35.7%110 up, 8 downMay 11, 2026$106.92M
    Dec 31, 2025$0.05$0.07-$0.02 - $0.12-28.57%Miss-66.7%120 up, 1 downFeb 26, 2026$103.65M
    Sep 30, 2025$0.14$0.11$0.10 - $0.12+27.27%Beat+7.7%101 up, 4 downNov 6, 2025$90.89M
    Jun 30, 2025$0.07$0.10$0.09 - $0.12-30.00%Miss0.0%100 up, 2 downAug 6, 2025$92.36M
    Mar 31, 2025$0.14$0.11$0.10 - $0.12+27.27%Beat+40.0%103 up, 0 downMay 5, 2025$106.00M
    Dec 31, 2024$0.15$0.13$0.12 - $0.15+19.62%Beat+66.7%92 up, 1 downFeb 26, 2025$100.36M
    Sep 30, 2024$0.13$0.11$0.10 - $0.12+18.18%Beat+18.2%91 up, 0 downNov 6, 2024$94.82M
    Jun 30, 2024$0.07$0.10$0.10 - $0.11-30.00%Miss-41.7%90 up, 0 downAug 6, 2024$93.31M
    Mar 31, 2024$0.10$0.10$0.08 - $0.110.00%In line-16.7%100 up, 0 downMay 7, 2024$96.65M
    Dec 31, 2023$0.09$0.11$0.08 - $0.14-18.18%Miss-43.8%90 up, 0 downFeb 29, 2024$88.01M
    Sep 30, 2023$0.11$0.11$0.10 - $0.120.00%In line+10.0%60 up, 0 downNov 8, 2023$85.58M
    Jun 30, 2023$0.12$0.13$0.12 - $0.14-7.69%Miss+33.3%70 up, 0 downAug 9, 2023$90.45M
    Mar 31, 2023$0.12$0.12$0.11 - $0.130.00%In line+9.1%70 up, 0 downMay 8, 2023$90.30M
    Dec 31, 2022$0.16$0.13$0.11 - $0.14+23.08%Beat+1500.0%60 up, 0 downMar 1, 2023$86.63M
    Sep 30, 2022$0.10$0.12$0.11 - $0.13-16.67%Miss+42.9%60 up, 0 downNov 7, 2022$84.70M
    Jun 30, 2022$0.09$0.11$0.10 - $0.12-18.18%Miss+200.0%60 up, 0 downAug 9, 2022$82.76M
    Mar 31, 2022$0.11$0.11$0.04 - $0.120.00%In line+83.3%50 up, 0 downMay 5, 2022$81.55M
    Dec 31, 2021$0.01$0.09$0.06 - $0.11-88.89%Miss-88.9%50 up, 0 downMar 1, 2022$75.35M
    Sep 30, 2021$0.07$0.06$0.05 - $0.06+16.67%Beat+133.3%4N/ANov 9, 2021$73.94M
    Jun 30, 2021$0.03$0.05$0.04 - $0.06-40.00%MissN/A6N/AAug 5, 2021$70.10M
    Mar 31, 2021$0.06$0.05$0.04 - $0.05+20.00%BeatN/A4N/AMay 6, 2021$66.72M
    Dec 31, 2020$0.09$0.03$0.02 - $0.05+200.00%BeatN/A3N/AMar 4, 2021$64.64M
    Sep 30, 2020$0.03$0.02N/A+50.00%BeatN/AN/AN/ADec 14, 2020$60.32M
    Sep 30, 2019-$0.05N/AN/AN/AN/AN/AN/AN/ADec 31, 2019$53.49M
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.40, down 11.1% from the year before. It was $0.07 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.40-11.1%
    Dec 31, 2024$0.45N/A
    Dec 31, 2023$0.44N/A
    Dec 31, 2022$0.46+170.6%
    Dec 31, 2021$0.17+127.9%
    Dec 31, 2020$0.07N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,800 words across 13 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,76613
    2026Q2Jun 30, 20265,39613
    2026Q1Mar 31, 20266,60914
    2025Q4Dec 31, 20258,00413
    2025Q3Sep 30, 20255,19312
    2025Q2Jun 30, 20256,36513
    2025Q1Mar 31, 20255,96313
    2024Q4Dec 31, 20246,26212

    2026Q3 Earnings Call

    Opening remarks

    Jay Liu Investor Relations Good morning, everyone. Thank you all for participating in today's conference call. On the call from Certara, we have Jon Resnick, Chief Executive Officer, and Faiz Mohammed, Interim Chief Financial Officer. Earlier today, Certara released financial results for the quarter ending September 30, 2026. A copy of the press release is available on the company's website. Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements, and actual results may differ materially from those expressed or implied in the forward-looking statements. Please refer to slide two in the accompanying presentation titled "Third Quarter 2026 Financial Results" for additional information, which you can find on the company's investor relations website. In the remarks or responses to questions, management may mention some non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are available in the recent earnings press release on the company's website. Please refer to the reconciliation tables in the accompanying materials for additional information. This conference call contains time-sensitive information and is accurate only as of today, November 5, 2026. Certara disclaims any obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. With that, I will turn the call over to Jon.

    Jon Resnick CEO Thank you, Jay. Thank you all for joining today. When I hosted my first earnings call in February, I shared with you my initial impressions of Certara: that we have an extraordinary business, one that is strategically critical to the future of drug development. On that February call, I also shared that 2026 would be about improving the ways we operate, reinvigorating growth, and setting the business up to realize its full potential. What followed was attention to a focused strategy and targeted portfolio businesses, placing customers at the center of everything we do, and a dedication to execution and operations. Over the past three quarters, we have completed the divestiture of the Regulatory and Medical Writing business, reorganized our business around how customers buy our software and services, and brought in key talent to strengthen our commercial and product leadership teams. We have also moved quickly to embed AI across our offerings and our operations, and to define a multi-pronged strategy to accelerate growth. There is more work to do, but we are executing against that plan. Turning to Q3, I am pleased to say the business is showing signs of strengthening. Revenue for the quarter was $94.9 million, up 4% year-over-year on a continuing operations basis.

    Frequently Asked Questions About CERT

    When is Certara's next earnings date?

    Certara's next earnings report is expected for Feb 24, 2027.

    Did CERT beat earnings estimates last quarter?

    Yes. Certara reported EPS of $0.06 for the quarter ended Sep 30, 2026, above the $0.05 estimate, a 20.00% surprise.

    What EPS do analysts expect from CERT next quarter?

    The consensus EPS estimate for Certara for the quarter ending Dec 31, 2026 is $0.10 from 15 analysts, with estimates from $0.09 to $0.13.

    How often does CERT beat earnings estimates?

    Certara beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.09%.